Reduction of motion sickness with an enhanced placebo instruction: An experimental study with healthy participants

Psychosomatic Medicine

Volumn 75, Issue 5, 2013, Pages 497-504

  Horing, Björn ^a   Weimer, Katja ^a   Schrade, Damaris ^a   Muth, Eric R ^b   Scisco, Jenna L ^b   Enck, Paul ^a   Klosterhalfen, Sibylle ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONDITIONING; DOSE RESPONSE; ELECTROGASTROGRAPHY; EXPERIMENTAL STUDY; FEMALE; HEAD MOVEMENT; HUMAN; MALE; MOTION SICKNESS; NORMAL HUMAN; OUTCOME VARIABLE; PERCEPTION; PLACEBO EFFECT; PRIORITY JOURNAL; ROTATION; VELOCITY;

EID: 84879880093     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3182915ee7     Document Type: Article

References (37)

1. Enck P, Bingel U, Schedlowski M, Rief M. Minimize, maximize or personalize: what to do with the placebo response in medicine? Nat Rev Drug Disc. In press
2. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Ther 2011;90:722-6
3. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioningactivated specific subsystems. J Neurosci 1999;19:484-94 (Pubitemid 29028987)
4. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-23 (Pubitemid 36958452)
5. Aslaksen PM, Bystad M, Vambheim SM, Flaten MA. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom Med 2011;73:193-9
6. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009;63:533-43
7. Hróbjartsson A, GLtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010;1:CD003974
8. Miller KE, Muth ER. Efficacy of acupressure and acustimulation bands for the prevention of motion sickness. Aviat Space Environ Med 2004;75: 227-34 (Pubitemid 38332371)
9. Bertolucci LE, DiDario B. Efficacy of a portable acustimulation device in controlling seasickness. Aviat Space Environ Med 1995;66:1155-8 (Pubitemid 26004095)
10. Lee A, Fan LT. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2009;2:CD003281
11. Zhang Z,Wang Y,Wang Y, Xu F. Antiemetic placebo: reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients. Med Hypotheses 2008;70:551-5 (Pubitemid 351179918)
12. Matthews A, Dowswell T, Haas DM, Doyle M, O'Mathúna DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2010;CD007575
13. Stockhorst U, Spennes-Saleh S, Körholz D, Göbel U, Schneider ME, Steingrüber HJ, Klosterhalfen S. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: features of a classically conditioned response? Brain Behav Immun 2000; 14:198-218 (Pubitemid 32280875)
14. Bovbjerg DH, Redd WH, Jacobsen PB, Manne SL, Taylor KL, Surbone A, Crown JP, Norton L, Gilewski TA, Hudis CA, Reichman BS, Kaufman RJ, Currie VE, Hakes TB. An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med 1992;54:623-37
15. Klosterhalfen S, Rüttgers A, Krumrey E, Otto B, Stockhorst U, Riepl RL, Probst T, Enck P. Pavlovian conditioning of taste aversion using a motion sickness paradigm. Psychosom Med 2000;62:671-7
16. Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingrüber HJ. Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiol Behav 1998;64:743-53 (Pubitemid 28470593)
17. Klosterhalfen S, Kellermann S, Stockhorst U, Wolf J, Kirschbaum C, Hall G, Enck P. Latent inhibition of rotation chair-induced nausea in healthy male and female volunteers. Psychosom Med 2005;67:335-40 (Pubitemid 40410972)
18. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P. Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 2009;66:323-8
19. Levine ME, Stern RM, Koch KL. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea. Psychosom Med 2006;68:478-86 (Pubitemid 44297682)
20. Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998;47:507-16 (Pubitemid 29095361)
21. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians'diagnoses. JAffect Disord 2004;78:131-40 (Pubitemid 38045472)
22. Schandry R. Heart beat perception and emotional experience. Psychophysiology 1981;18:483-8 (Pubitemid 11059862)
23. Herbert BM, Muth ER, Pollatos O, Herbert C. Interoception across modalities: on the relationship between cardiac awareness and the sensitivity for gastric functions. PLoS One 2012;7:e36646
24. Matchock RL, Levine ME, Gianaros PJ, Stern RM. Susceptibility to nausea and motion sickness as a function of the menstrual cycle. Womens Health Issues 2008;18:328-35
25. Meissner K, Enck P, Muth ER, Kellermann S, Klosterhalfen S. Cortisol levels predict motion sickness tolerance in women but not in men. Physiol Behav 2009;97:102-6
26. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77 (Pubitemid 34192886)
27. Muth ER, Elkins AN. High dose ondansetron for reducing motion sickness in highly susceptible subjects. Aviat Space Environ Med 2007;78:686-92 (Pubitemid 47047801)
28. Stern RM, Koch KL, Stewart WR, Lindblad M. Spectral analysis of tachygastria recorded during motion sickness. Gastroenterology 1987; 92:92-7 (Pubitemid 17207665)
29. Stern RM, Koch KL, Leibowitz HW, Lindblad IM, Shupert CL, Stewart WR. Tachygastria and motion sickness. Aviat Space Environ Med 1985;56: 1074-7 (Pubitemid 16214693)
30. Meissner K. Effects of placebo interventions on gastric motility and general autonomic activity. J Psychosom Res 2009;66:391-8
31. Weimer K, Horing B, Stürmer J, Klosterhalfen S, Zipfel S, Enck P. Nicotine expectancy differentially affects reaction time in healthy non-smokers and smokers depending on gender. Exp Clin Psychopharmacol. In press
32. Rohsenow DJ, Marlatt GA. The balanced placebo design: methodological considerations. Addict Behav 1981;6:107-22 (Pubitemid 11050255)
33. Enck P, Klosterhalfen S, Zipfel S. Novel study designs to investigate the placebo response. BMC Med Res Methodol 2011;11:90
34. Mallery RM, Olomu OU, Uchanski RM, Militchin VA, Hullar TE. Human discrimination of rotational velocities. Exp Brain Res 2010;204:11-20
35. Hu S, Stern RM, Vasey MW, Koch KL. Motion sickness and gastric myoelectric activity as a function of speed of rotation of a circular vection drum. Aviat Space Environ Med 1989;60:411-4 (Pubitemid 19121147)
36. Boakes RA, Tarrier N, Barnes BW, Tattersall MH. Prevalence of anticipatory nausea and other side-effects in cancer patients receiving chemotherapy. Eur J Cancer 1993;29:866-70 (Pubitemid 23083619)
37. Kaptchuk TJ, Kelley JM, Deykin A, Wayne PM, Lasagna LC, Epstein IO, Kirsch I, Wechsler ME. Do ''placebo responders'' exist? Contemp Clin Trials 2008;29:587-95.